Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

EPIC PHARMA LLC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve NABUMETONE

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 52
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

MYLAN

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve KETOPROFEN

Comment Full text

RK PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

VPNA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve NABUMETONE

Comment Full text

DR REDDYS LA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 51
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve KETOPROFEN

Comment Full text

STEVENS J

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Comment Full text
  • Previous
  • 297
  • 298
  • 299
  • 300
  • 301
  • Next

Search

News categories

  • Technical Exchange News(11488)
  • Event(3309)
  • SEC News(213605)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137185)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin